Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 146

1.

Long-term virologic response and genotypic resistance mutations in HIV-1 infected Kenyan children on combination antiretroviral therapy.

Wamalwa DC, Lehman DA, Benki-Nugent S, Gasper MA, Gichohi R, Maleche-Obimbo E, Farquhar C, John-Stewart GC, Overbaugh J.

J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):267-74. doi: 10.1097/QAI.0b013e31827b4ac8.

PMID:
23196827
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
[PubMed - indexed for MEDLINE]
3.

Rate of virologic failure and selection of drug resistance mutations using different triple nucleos(t)ide analogue combinations in HIV-infected patients.

Martín-Carbonero L, Gil P, García-Benayas T, Barreiro P, Blanco F, de Mendoza C, Maida I, González-Lahoz J, Soriano V.

AIDS Res Hum Retroviruses. 2006 Dec;22(12):1231-5.

PMID:
17209764
[PubMed - indexed for MEDLINE]
4.

Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure.

Beck IA, Jang M, McKernan-Mullin J, Bull M, Wagner T, Huang S, Song LY, Nachman S, Krogstad P, Eshleman SH, Wiznia A, Frenkel LM.

AIDS Res Hum Retroviruses. 2012 Aug;28(8):780-8. doi: 10.1089/AID.2011.0039. Epub 2012 Jan 27.

PMID:
22081867
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China.

Liao L, Xing H, Su B, Wang Z, Ruan Y, Wang X, Liu Z, Lu Y, Yang S, Zhao Q, Vermund SH, Chen RY, Shao Y.

AIDS. 2013 Jul 17;27(11):1815-24. doi: 10.1097/QAD.0b013e3283611931.

PMID:
23803794
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Drug resistance profiles among HIV-1-infected children experiencing delayed switch and 12-month efficacy after using second-line antiretroviral therapy: an observational cohort study in rural China.

Zhao Y, Mu W, Harwell J, Zhou H, Sun X, Cheng Y, Li C, Zhang F.

J Acquir Immune Defic Syndr. 2011 Sep 1;58(1):47-53. doi: 10.1097/QAI.0b013e318229f2a2.

PMID:
21725248
[PubMed - indexed for MEDLINE]
7.

Antiviral resistance and correlates of virologic failure in the first cohort of HIV-infected children gaining access to structured antiretroviral therapy in Lima, Peru: a cross-sectional analysis.

Rath BA, von Kleist M, Castillo ME, Kolevic L, Caballero P, Soto-Castellares G, Amedee AM, Robinson JE, Katzenstein DK, Van Dyke RB, Oberhelman RA.

BMC Infect Dis. 2013 Jan 2;13:1. doi: 10.1186/1471-2334-13-1.

PMID:
23280237
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapine.

Gupta RK, Ford D, Mulenga V, Walker AS, Kabamba D, Kalumbi M, Grant PR, Ferrier A, Pillay D, Gibb DM, Chintu C.

Pediatr Infect Dis J. 2010 Aug;29(8):e57-62. doi: 10.1097/INF.0b013e3181e47609.

PMID:
20508547
[PubMed - indexed for MEDLINE]
9.

Long-term effectiveness of combination antiretroviral therapy and prevalence of HIV drug resistance in HIV-1-infected children and adolescents in Rwanda.

Mutwa PR, Boer KR, Rusine J, Muganga N, Tuyishimire D, Schuurman R, Reiss P, Lange JM, Geelen SP.

Pediatr Infect Dis J. 2014 Jan;33(1):63-9. doi: 10.1097/INF.0b013e31829e6b9f.

PMID:
24352189
[PubMed - indexed for MEDLINE]
10.

Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.

Jittamala P, Puthanakit T, Chaiinseeard S, Sirisanthana V.

Pediatr Infect Dis J. 2009 Sep;28(9):826-30. doi: 10.1097/INF.0b013e3181a458f9.

PMID:
19654564
[PubMed - indexed for MEDLINE]
11.

Pediatric response to second-line antiretroviral therapy in South Africa.

Zanoni BC, Sunpath H, Feeney ME.

PLoS One. 2012;7(11):e49591. doi: 10.1371/journal.pone.0049591. Epub 2012 Nov 20.

PMID:
23185373
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Outcomes after virologic failure of first-line ART in South Africa.

Murphy RA, Sunpath H, Lu Z, Chelin N, Losina E, Gordon M, Ross D, Ewusi AD, Matthews LT, Kuritzkes DR, Marconi VC; South Africa Resistance Cohort Study Team.

AIDS. 2010 Apr 24;24(7):1007-12. doi: 10.1097/QAD.0b013e3283333639.

PMID:
20397305
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Antiretroviral resistance in HIV-infected Saudi children failing first-line highly active antiretroviral therapy.

Al Hajjar SH, Frayha H, Althawadi S.

Ann Saudi Med. 2012 Nov-Dec;32(6):565-9. doi: 10.5144/0256-4947.2012.565.

PMID:
23396017
[PubMed - indexed for MEDLINE]
14.

Efficient monitoring of HIV-1 vertically infected children in Kenya on first-line antiretroviral therapy.

Lihana RW, Lwembe RM, Bi X, Ochieng W, Panikulam A, Palakudy T, Musoke R, Owens M, Ishizaki A, Okoth FA, Songok EM, Ichimura H.

J Clin Virol. 2011 Oct;52(2):123-8. doi: 10.1016/j.jcv.2011.06.014. Epub 2011 Jul 27.

PMID:
21798798
[PubMed - indexed for MEDLINE]
15.

Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.

Chang LW, Harris J, Humphreys E.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008494. doi: 10.1002/14651858.CD008494. Review.

PMID:
20393969
[PubMed - indexed for MEDLINE]
16.

Outcomes of second combination antiretroviral therapy regimens among HIV-infected persons in clinical care: a multicenter cohort study.

Napravnik S, Eron JJ, Sterling TR, Juday T, Uy J, Moore RD.

AIDS Res Hum Retroviruses. 2013 Mar;29(3):574-80. doi: 10.1089/AID.2012.0210. Epub 2012 Nov 12.

PMID:
23072322
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan children.

Musiime V, Kaudha E, Kayiwa J, Mirembe G, Odera M, Kizito H, Nankya I, Ssali F, Kityo C, Colebunders R, Mugyenyi P.

AIDS Res Hum Retroviruses. 2013 Mar;29(3):449-55. doi: 10.1089/aid.2012.0283. Epub 2013 Jan 11.

PMID:
23308370
[PubMed - indexed for MEDLINE]
18.

Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings.

Hosseinipour MC, Gupta RK, Van Zyl G, Eron JJ, Nachega JB.

J Infect Dis. 2013 Jun 15;207 Suppl 2:S49-56. doi: 10.1093/infdis/jit107. Review.

PMID:
23687289
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Extensive drug resistance in HIV-infected Cambodian children who are undetected as failing first-line antiretroviral therapy by WHO 2010 guidelines.

Coetzer M, Westley B, Delong A, Tray C, Sophearin D, Nerrienet E, Schreier L, Kantor R.

AIDS Res Hum Retroviruses. 2013 Jul;29(7):985-92. doi: 10.1089/AID.2013.0025. Epub 2013 Apr 27.

PMID:
23506238
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Virological response and resistance profiles after 18 to 30 months of first- or second-/third-line antiretroviral treatment: a cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic.

Charpentier C, Gody JC, Mbitikon O, Moussa S, Matta M, Péré H, Fournier J, Longo Jde D, Bélec L.

AIDS Res Hum Retroviruses. 2012 Jan;28(1):87-94. doi: 10.1089/AID.2011.0035. Epub 2011 Jun 20.

PMID:
21599597
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk